Status:
COMPLETED
Effect of Hearing Aid Labeling on Speech Understanding Measures
Lead Sponsor:
Sonova AG
Conditions:
Hearing Loss
Eligibility:
All Genders
18-95 years
Phase:
NA
Brief Summary
New and experienced hearing aid users will be fit with two hearing devices. One will be labeled as an OTC (Over-The-Counter) device, the other will be labeled as a Prescriptive (i.e. professionally fi...
Eligibility Criteria
Inclusion
- Adults age 18 or older with bilateral mild to moderate hearing loss
- Experienced users must have at least 6 months Hearing Aid experience
- New users must have no prior hearing aid experience, defined as never owning their own devices
Exclusion
- Self-reported ear related pathology (otorrhea w/in 90 days, dizziness, sudden hearing loss or worsening of hearing w/in 90 days, otalgia)
- Visible deformity of the ear
- Chronic, severe tinnitus
- Unilateral hearing loss
- Cognitive impairment
Key Trial Info
Start Date :
May 26 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 16 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05274178
Start Date
May 26 2022
End Date
June 16 2022
Last Update
July 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sonova US
Aurora, Illinois, United States, 60505